Millennium Management
ELOX

Millennium Management’s Eloxx Pharmaceuticals, Inc. Common Stock ELOX Stock Holding History

Millennium Management’s Portfolio ELOX Stock Details ELOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,647
Closed -$59K – 7783
2022
Q1 		$59K Sell
2,647
-1,742
-40% -$34.3K ﹤0.01% 6348
2021
Q4 		$123K Sell
4,389
-2,468
-36% -$108K ﹤0.01% 6176
2021
Q3 		$447K Sell
6,857
-2,986
-30% -$184K ﹤0.01% 5459
2021
Q2 		$783K Buy
+9,843
New +$821K ﹤0.01% 4902
2020
Q1 		– Sell
-982
Closed -$289K – 4721
2019
Q4 		$289K Buy
982
+525
+115% +$106K ﹤0.01% 3683
2019
Q3 		$82K Sell
457
-83
-15% -$23.6K ﹤0.01% 3990
2019
Q2 		$215K Buy
+540
New +$227K ﹤0.01% 3721

Other funds holding ELOX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
AFG
American Financial Group Cincinnati, Ohio $270M AUM 3.25% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
AS
Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Millennium Management's ELOX Position: Q2 2022 in Review

Millennium Management sold out of Eloxx Pharmaceuticals, Inc. Common Stock (ELOX) in Q2 2022, closing a stake of 2,647 shares — an estimated $59K sold.

Millennium Management first reported a position in ELOX in Q2 2019 and held it in 7 quarters. The position peaked at $783K in Q2 2021. 30 funds tracked by Wall St. Rank hold ELOX as of Q2 2022.

  • Millennium Management reported no remaining Eloxx Pharmaceuticals, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Millennium Management sold 2,647 Eloxx Pharmaceuticals, Inc. Common Stock shares in Q2 2022, an estimated $59K.
  • Millennium Management first reported a position in Eloxx Pharmaceuticals, Inc. Common Stock in Q2 2019 and held it in 7 quarters.
  • Millennium Management's Eloxx Pharmaceuticals, Inc. Common Stock position peaked at $783K in Q2 2021.
  • 30 funds tracked by Wall St. Rank held Eloxx Pharmaceuticals, Inc. Common Stock as of Q2 2022.

Based on Millennium Management's 13F filing for Q2 2022, filed 15 Aug 2022.